【摘要】 近几十年来,食管胃结合部腺癌的发病率正在逐年上升。Her-2表达与食管胃结合部腺癌预后的研究结果呈现争议,研究认为这是因为Her-2检测的局限性和组织标本的异质性而导致不同的结果。对于Her-2过表达的食管胃结合部腺癌,综合治疗包括新辅助放化疗、辅助放化疗、手术治疗及靶向治疗在临床疗效中的地位越来越突出,中医药治疗也在辅助治疗中起到重要作用。更多还原

【Abstract】 In recent decades,the incidence of gastroesophageal junction(GEJ)adenocarcinomas is increasing. The relationship between Her-2 expression and prognosis of GEJ adenocarcinomas shows controversy. It leads to different results because of Her-2 detection limitations and tissue heterogeneity. For GEJ adenocarcinomas with Her-2 overexpression,comprehensive therapy including neoadjuvant chemotherapy,adjuvant radiotherapy,surgery and targeted therapy is becoming more and more prominent in the clinic. Traditional Chinese medicine has played an important role in the adjuvant therapy.更多还原